本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

奥麦罗制药

6.35
+0.01000.16%
盘后6.32-0.0300-0.47%18:18 EDT
成交量:37.45万
成交额:238.94万
市值:3.69亿
市盈率:-2.36
高:6.50
开:6.33
低:6.27
收:6.34
数据加载中...
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/16

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses